In the propensity score-matched cohort, SRH patients exhibited a trend towards a higher risk of MASLD, but this did not reach statistical significance (in Model 3, HR 95% CI: 1.112 [0.848–1.460], P = 0.442).
← all excerpts
Exploring the nexus between hypothyroidism and metabolic dysfunction-associated steatotic liver disease: a UK biobank cohort study.
1
0.4420
0.4420